Clinical phenome scanning

Personalized Medicine

Volumn 4, Issue 2, 2007, Pages 175-182

  Ghebranious, Nader ^a   McCarty, Catherine A ^a   Wilke, Russell A ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

Biobank; Clinical phenome scan; Common diseases; DNA; Phenomic markers; Pleiotropy

Indexed keywords

APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE; LEUKOCYTE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

ALGORITHM; ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL GENETICS; COHORT ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DNA POLYMORPHISM; EFFECT SIZE; ELECTRONIC MEDICAL RECORD; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE MAP; HEALTH SERVICE; HEART INFARCTION; HUMAN; HYPERTENSION; INFORMED CONSENT; LINKAGE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PLEIOTROPY; POPULATION GENETICS; PRIORITY JOURNAL; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 34249820776     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/17410541.4.2.175     Document Type: Article

References (17)

1. Collins FS, Green ED, Guttmacher AE. Guyer MS; US National Human Genome Research Institute: A vision for the future of genomics research. Nature 422, 835-847 (2003).
2. Moore JH: A global view of epistasis. Nat. Genet. 37, 13-14 (2005).
3. Wilke RA, Reif DM, Moore JH: Combinatorial pharmacogenetics. Nat. Rev. Drug Discov. 4, 911-918 (2005).
4. McCarty CA, Wilke RA, Giampietro PF, Wesbrook SD, Caldwell MD: Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank. Personalized Med. 2. 49-79 (2005).
5. Davis RL, Khoury MJ: The journey to personalized medicine. Personalized Med. 2, 1-4 (2005).
6. Yang Q, Khoury MJ, Friedman J. Little J. Flanders WD: How many genes underlie the occurrence of common complex diseases in the population? Int. J. Epidemiol. 34, 1129-1137 (2005).
7. International HapMap Consortium: A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
8. Falk CT: Risk factors for coronary artery disease and the use of neural networks to predict the presence or absence of high blood pressure. BMC Genet. 4, S67 (2003).
9. Baldassarre D, Grossi E, Buscema M et al.: Recognition of patients with cardiovascular disease by artificial neural networks. Ann. Med. 36, 630-640 (2004).
10. Tomita Y, Tomida S. Hasegawa Y et al.: Artificial neural network approach for selection of susceptible single nucleotide polymorphisms and construction of prediction model on childhood allergic asthma. BMC Bioinformatics 5. 120 (2004).
11. Sherriff A, Ott J; ALSPAC Study Team: Artificial neural networks as statistical tools in epidemiological studies: analysis of risk factors for early infant wheeze. Paediatr. Perinat. Epidemiol. 18, 456-463 (2004).
12. Jones R, Pembrey M, Golding J. Herrick D: The search for genotype/ phenotype associations and the phenome scan. Paediatr. Perinat. Epidemiol. 19, 264-275 (2005).
13. Bhatti P. Sigurdson AJ, Wang SS et al.: Genetic variation and willingness to participate in epidemiologic research: data from three studies. Cancer Epidemiol. Biomarkers Prev. 14, 2449-2453 (2005).
14. Freimer N. Sabatti C: The human phenome project. Nat. Genet. 34, 15-21 (2003).
15. van Driel MA, Bruggeman J, Vriend G, Brunner HG, Leunissen JA: A text-mining analysis of the human phenome. Eur. J. Hum. Genet. 14. 535-542 (2006).
16. Freudenberg J, Zimmer R, Hanisch D, Lengauer T: A hypergraph-based method for unification of existing protein structure- and sequence-families. In Silico Biol. 3, 339-349 (2002).
17. Lage K, Karlberg EO, Storling ZM et al.: A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat. Biotechnol. 25, 309-316 (2007).